As vaccine technologies evolve, from traditional attenuated viruses to recombinant proteins and mRNA platforms, the role of experienced vaccines CDMO companies has never been more critical. These specialized contract development and manufacturing organizations provide the infrastructure, technical expertise, and regulatory knowledge required to bring vaccines from concept to commercial production.
Whether you’re a biotech developing a novel prophylactic or a pharmaceutical company scaling up a therapeutic vaccine, working with trusted vaccines contract manufacturing partners ensures speed, safety, and scalability.
How to Choose Vaccines CDMO Companies
Choosing the right vaccines CDMO is essential for successful development, scale-up, and regulatory approval. Key factors to evaluate include:
- Platform experience: Proven capabilities in live-attenuated, inactivated, subunit, viral vector, or mRNA vaccine platforms.
- Process development expertise: Strong support for upstream (cell culture, fermentation) and downstream (purification, formulation) workflows.
- Fill-finish capabilities: Sterile vialing or prefilled syringes in compliance with GMP standards.
- Regulatory readiness: Experience with FDA, EMA, WHO PQ, and global health agency approvals.
- Cold chain management: Support for ultra-low temperature storage and distribution.
- Clinical to commercial scalability: Capacity to transition smoothly through development phases.
Working with a CDMO that aligns with your platform and regulatory path greatly reduces time and risk.
Key Services Offered by Vaccines Contract Manufacturers
Top-tier vaccines contract manufacturing providers typically offer:
- Cell line and virus seed development
- Upstream production: Using Vero, CHO, HEK293, or E. coli systems.
- Purification and inactivation processes tailored to vaccine modality.
- mRNA synthesis and LNP formulation
- Sterile fill-finish, visual inspection, and labeling.
- Analytical development and QC testing: Potency, endotoxins, sterility.
- GMP manufacturing: For clinical trial material and commercial launch.
- Global regulatory support and dossier preparation.
These services support the full lifecycle of vaccine development, from early research through global distribution.
Advantages of Partnering with Vaccines CDMO Companies
Choosing specialized vaccines CDMO companies provides measurable benefits:
- Platform versatility: Across viral, bacterial, recombinant, and nucleic acid vaccines.
- Faster time to clinic: Through integrated development and manufacturing processes.
- Access to proprietary technologies: Such as adjuvants or nanoparticle delivery.
- Strong regulatory track record: With approvals in major markets.
- Reliable global supply chain: And cold chain infrastructure.
These CDMOs serve as strategic partners — not just manufacturers — enabling innovation and global access.
Vaccines CDMO Companies
- 53Biologics: CDMO specialized in biologics production from DNA to proteins, providing preclinical to cGMP manufacturing. [See CDMO profile]
- Mabion: Fully integrated CDMO offering development and GMP manufacturing of biotherapeutics, including monoclonal antibodies and recombinant proteins. [See CDMO profile]
- Shilpa Biologicals: Supports process development, gene to cell line development, GMP manufacturing, formulation development, analytical development, fill-finish, and packaging. [See CDMO profile]
- HIPRA BIOTECH SERVICES: End-to-end capabilities from cell line development to commercial manufacturing. [See CDMO profile]
- Cultiply: Spanish CDMO developing production and purification processes for recombinant proteins, enzymes, DNA, and other bioderived products. [See CDMO profile]
- Rodon Biologics: Provides development of biopharmaceutical products, antibodies, peptides, proteins, and hormones for third parties. [See CDMO profile]
- CZ Vaccines: Single-use commercial scale facility. [See CDMO profile]
- Adragos Pharma: Specializes in aseptic manufacturing of lyophilized or liquid sterile biopharmaceuticals through fill-and-finish. [See CDMO profile]
- Demo facility: Tissue therapy, Cell therapy and GTMP (Gene Therapy). [See CDMO profile]
- Bilthoven Biologicals Drug Substance and Drug Product Facilities: Multi-product GMP facilities for Drug Substance and Drug Product. [See CDMO profile]
Related Information
Let MAI CDMO Network Help You Find the Right Vaccines CDMO Partner
At MAI CDMO Network, we connect companies with the most capable vaccines CDMO companies worldwide, whether you’re producing a next-gen mRNA vaccine or scaling a live-attenuated product. Our network of vaccines contract manufacturing partners is built to help you meet development timelines, quality requirements, and regulatory expectations with confidence.
Need a reliable vaccine manufacturing partner? Contact us today to find the right fit for your platform and pipeline.